On May 7 and 8, Relatech will participate as Gold Sponsor at the ESAC 1st Annual Meeting & 4th Edition AI for Oncology and Cancer Research, taking place at Politecnico di Milano.
The event will bring together medical oncologists, radiologists, pathologists, researchers, data scientists, engineers and healthcare professionals to discuss one of the most relevant topics for the future of healthcare: how to apply artificial intelligence to oncology research and clinical practice in a safe, reliable and meaningful way.
Healthcare organizations today generate an increasing amount of data. Electronic health records, diagnostic imaging, laboratory systems, genomic data, connected devices and research platforms produce valuable information, but this data is often distributed across different environments, stored in different formats and not always properly integrated.
This is one of the main challenges behind AI adoption in healthcare. Without integrated, interoperable, secure and governed data, even the most advanced AI solutions can struggle to move into real-world clinical and research settings.
Relatech’s Digital Business Unit works at this intersection between data, platforms and artificial intelligence. We support healthcare organizations in building scalable data architectures, interoperability solutions, advanced analytics and AI systems designed to transform fragmented data into actionable insight for research, clinical processes and decision-making.
Taking part in ESAC is an opportunity for us to contribute to an essential conversation: moving AI beyond experimentation and toward concrete, secure and sustainable applications in healthcare. During the event, our team will be available at a dedicated desk to share our healthcare expertise and present the demo we are bringing to Milan.
